Compare ICG & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICG | XTNT |
|---|---|---|
| Founded | 2017 | N/A |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.7M | 82.6M |
| IPO Year | 2023 | N/A |
| Metric | ICG | XTNT |
|---|---|---|
| Price | $1.81 | $0.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $7.50 | $1.50 |
| AVG Volume (30 Days) | ★ 577.6K | 241.7K |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 94.43 | N/A |
| EPS | ★ 0.21 | 0.01 |
| Revenue | $36,367,850.00 | ★ $133,083,000.00 |
| Revenue This Year | N/A | $15.95 |
| Revenue Next Year | $75.98 | N/A |
| P/E Ratio | ★ $8.63 | $62.97 |
| Revenue Growth | 6.53 | ★ 16.88 |
| 52 Week Low | $0.93 | $0.33 |
| 52 Week High | $12.04 | $0.95 |
| Indicator | ICG | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 62.99 | 62.70 |
| Support Level | $1.73 | $0.59 |
| Resistance Level | $1.77 | $0.66 |
| Average True Range (ATR) | 0.18 | 0.04 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 70.69 | 92.68 |
Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.